Alternatively, interferon-gamma pathway activation has been associated with chemotherapy resistance, immune exhaustion, BCL2 inhibitors, venetoclax (VEN), and resistance in AML with high MHC class I and II expression, suggesting that this pathway has dual roles for immune activation and immune suppression [26]. The gene discussed is IFNG; the disease is acute myeloid leukemia.